Get startedLog in
    Picture of Island Pharmaceuticals logo

    ILA — Island Pharmaceuticals Income Statement

    0.000.00%
    au flag iconLast trade - 00:00
    HealthcareSpeculativeMicro CapMomentum Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Island Pharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

    2020
    June 30th
    2021
    June 30th
    2022
    June 30th
    2023
    June 30th
    2024
    June 30th
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue0000.0110.005
    Selling / General / Administrative Expenses
    Research And Development
    Other Operating Expenses
    Total Operating Expenses0.0012.142.812.912.86
    Operating Profit-0.001-2.14-2.81-2.9-2.86
    Total Net Non Operating Interest Income / Expense
    Net Income Before Taxes-0.001-2.13-2.61-2.83-2.86
    Provision for Income Taxes
    Net Income After Taxes-0.001-2.13-2.61-2.83-2.86
    Net Income Before Extraordinary Items
    Net Income-0.001-2.13-2.61-2.83-2.86
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-0.001-2.13-2.61-2.83-2.86
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-0-0.023-0.029-0.031-0.032
    Dividends per Share